UK markets closed
NIKKEI 225
38,835.10 +599.03 (+1.57%) HANG SENG
18,479.37 -98.93 (-0.53%) CRUDE OIL
78.56 +0.08 (+0.10%) GOLD FUTURES
2,322.50 -8.70 (-0.37%) DOW
38,884.26 +31.99 (+0.08%) Bitcoin GBP
50,396.74 -242.25 (-0.48%)
Amneal Pharmaceuticals, Inc. (2DT.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 09:59AM CEST
| Previous close | 6.20 |
| Open | 6.10 |
| Bid | 5.95 x 0 |
| Ask | 6.20 x 0 |
| Day's range | 6.10 - 6.10 |
| 52-week range | 1.60 - 6.20 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 1.882B |
| Beta (5Y monthly) | 1.35 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Amneal Pharmaceuticals First Quarter 2024 Earnings: US$0.30 loss per share (vs US$0.046 loss in 1Q 2023)
Amneal Pharmaceuticals ( NASDAQ:AMRX ) First Quarter 2024 Results Key Financial Results Revenue: US$659.2m (up 18% from...
- GuruFocus.com
Amneal Pharmaceuticals Inc (AMRX) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...
Amneal Pharmaceuticals reports significant revenue and EBITDA growth in Q1 2024, driven by new product launches and strong market performance.
- Simply Wall St.
Amneal Pharmaceuticals (NASDAQ:AMRX) shareholders are still up 235% over 1 year despite pulling back 8.0% in the past week
When you buy shares in a company, there is always a risk that the price drops to zero. On the other hand, if you find a...
© 2024 Yahoo. All rights reserved.